Johnson & Johnson
JNJ · NYSE
12/29/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $88,821 | $85,159 | $79,990 | $78,740 |
| % Growth | 4.3% | 6.5% | 1.6% | – |
| Cost of Goods Sold | $27,471 | $26,553 | $24,596 | $23,402 |
| Gross Profit | $61,350 | $58,606 | $55,394 | $55,338 |
| % Margin | 69.1% | 68.8% | 69.3% | 70.3% |
| R&D Expenses | $17,232 | $15,085 | $14,135 | $14,277 |
| G&A Expenses | $21,969 | $20,112 | $20,246 | $20,118 |
| SG&A Expenses | $21,969 | $20,112 | $20,246 | $20,118 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $39,201 | $35,197 | $34,381 | $34,395 |
| Operating Income | $22,149 | $23,409 | $21,013 | $20,943 |
| % Margin | 24.9% | 27.5% | 26.3% | 26.6% |
| Other Income/Exp. Net | -$5,462 | -$8,347 | -$1,654 | -$1,765 |
| Pre-Tax Income | $16,687 | $15,062 | $19,359 | $19,178 |
| Tax Expense | $2,621 | $1,736 | $2,989 | $1,377 |
| Net Income | $14,066 | $35,153 | $17,941 | $20,878 |
| % Margin | 15.8% | 41.3% | 22.4% | 26.5% |
| EPS | 5.84 | 13.88 | 6.83 | 7.93 |
| % Growth | -57.9% | 103.2% | -13.9% | – |
| EPS Diluted | 5.79 | 13.72 | 6.73 | 7.81 |
| Weighted Avg Shares Out | 2,407 | 2,534 | 2,614 | 2,629 |
| Weighted Avg Shares Out Dil | 2,429 | 2,560 | 2,664 | 2,674 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,332 | $1,261 | $490 | $53 |
| Interest Expense | $755 | $772 | $276 | $183 |
| Depreciation & Amortization | $7,339 | $7,486 | $6,970 | $7,390 |
| EBITDA | $24,781 | $23,320 | $26,605 | $26,751 |
| % Margin | 27.9% | 27.4% | 33.3% | 34% |